Companies: 10,795·Total market cap: $144.5T
Cardax, Inc.

Cardax, Inc.

CDXIOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$80
P/E Ratio
52W High$0.004
52W Low$0.000001

Cardax, Inc. (CDXI) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

CDXI · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
744,555 +9.47% YoY Change
FY · as of Dec 31, 2020 · Reported in USD
vs 680,152 in FY 2019
Diluted Shares Outstanding
744,555
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+9.47%
year-over-year
Float (Free Float)
590,202
publicly tradable shares
73.5% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+14.2%
2017 → 2020
5-Year CAGRincreasing
+17.4%
2015 → 2020
10-Year CAGR

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2020Latest
Diluted Shares: 744,555
744,555
+9.47%
FY 2019
Diluted Shares: 680,152
680,152
+6.85%
FY 2018
Diluted Shares: 636,524
636,524
+27.37%
FY 2017
Diluted Shares: 499,756
499,756
+31.12%
FY 2016
Diluted Shares: 381,137
381,137
+13.99%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs CDXI
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
Cardax, Inc.CDXI
Cardax, Inc.YOU
744,555

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Cardax, Inc. (CDXI) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2020, Cardax, Inc. reports 744,555 basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Cardax, Inc.'s basic shares outstanding (744,555) represents currently issued shares. Diluted shares outstanding (744,555) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Cardax, Inc.'s float is 590,202 (73.5% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float590,202(73.5%)
Outstanding802,516

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Cardax, Inc. (CDXI) shares outstanding history from 2012 to 2020. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Cardax, Inc. shares outstanding for the fiscal year ending December 31, 2020 were 744,555, a 9.47% increase year-over-year. Cardax, Inc. FY 2020 shares outstanding were 744,555, a +9.47% increase from FY 2019.

Cardax, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

CDXI shares outstanding · 4 questions

As of December 31, 2020, Cardax, Inc. (CDXI) has approximately 744,555 basic shares outstanding and 744,555 diluted shares outstanding. This represents a +9.47% year-over-year increase from FY 2019 (680,152). The increase may reflect equity compensation issuances or secondary offerings.

CDXI shares outstandinghow many shares does CDXI haveCDXI basic shares 2020CDXI diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Cardax, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10